Literature DB >> 4396163

A comparative clinical trial of different subcutaneous doses of terbutaline and orciprenaline in bronchial asthma.

B Arner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4396163     DOI： 10.1111/j.0954-6820.1970.tb05289.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN： 0365-463X


× No keyword cloud information.
  6 in total

1.  Clinical comparison of intramuscular terbutaline and subcutaneous adrenaline in bronchial asthma.

Authors:  S Johansen
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

2.  Effects of a new stimulator of beta-receptors, terbutaline, on ventilatory capacity, lung resistance, heart rate and blood pressure.

Authors:  B Elgefors; L Wilhelmsen
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

3.  A clinical and spirometric trial of a new receptor stimulant drug, terbutaline, in asthmaic patients.

Authors:  W D Linehan
Journal:  Ir J Med Sci       Date:  1973-05       Impact factor: 1.568

4.  Terbutaline: a preliminary report of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 5.  Drug therapy approaches in the treatment of acute severe asthma in hospitalised children.

Authors:  L K DeNicola; M O Gayle; K V Blake
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

6.  Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale.

Authors:  R A Stockley; P Finnegan; J M Bishop
Journal:  Thorax       Date:  1977-10       Impact factor: 9.139
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.